Your browser doesn't support javascript.
loading
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory.
Ndeupen, Sonia; Qin, Zhen; Jacobsen, Sonya; Bouteau, Aurélie; Estanbouli, Henri; Igyártó, Botond Z.
Afiliación
  • Ndeupen S; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia 19107 PA, USA.
  • Qin Z; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia 19107 PA, USA.
  • Jacobsen S; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia 19107 PA, USA.
  • Bouteau A; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia 19107 PA, USA.
  • Estanbouli H; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia 19107 PA, USA.
  • Igyártó BZ; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia 19107 PA, USA.
iScience ; 24(12): 103479, 2021 Dec 17.
Article en En | MEDLINE | ID: mdl-34841223

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: IScience Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: IScience Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos